Employees Retirement System of Texas’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-28,000
Closed -$778K – 1034
2019
Q2
$778K Hold
28,000
– – 0.01% 857
2019
Q1
$930K Hold
28,000
– – 0.01% 823
2018
Q4
$814K Hold
28,000
– – 0.01% 846
2018
Q3
$1.29M Buy
+28,000
New +$1.25M 0.02% 775

Other funds holding MYGN

Employees Retirement System of Texas's MYGN Position: Q3 2019 in Review

Employees Retirement System of Texas sold out of Myriad Genetics (MYGN) in Q3 2019, closing a stake of 28,000 shares — an estimated $778K sold.

Employees Retirement System of Texas first reported a position in MYGN in Q3 2018 and held it in 4 quarters. The position peaked at $1.29M in Q3 2018. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2019.

  • Employees Retirement System of Texas reported no remaining Myriad Genetics position as of Q3 2019 after selling out during the quarter.
  • Employees Retirement System of Texas sold 28,000 Myriad Genetics shares in Q3 2019, an estimated $778K.
  • Employees Retirement System of Texas first reported a position in Myriad Genetics in Q3 2018 and held it in 4 quarters.
  • Employees Retirement System of Texas's Myriad Genetics position peaked at $1.29M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2019.

Based on Employees Retirement System of Texas's 13F filing for Q3 2019, filed 12 Nov 2019.